Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Soft tissue sarcoma, adult
Stage/Subtype:  stage I adult soft tissue sarcoma
Country:  U.S.A.
Trial Type:  Treatment
Results 1-11 of 11 for your search:
Start Over
Proton Beam Radiation Therapy in Treating Patients With Extremity Soft Tissue Sarcoma
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: UPCC 09510, NCI-2012-00752, NCT01561495
Bevacizumab in Treating Patients With Soft Tissue Sarcoma
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: NU 04S1, NCI-2013-01399, NCT00288015
Proton Beam Radiation Therapy in Treating Patients with Previously Untreated Childhood Rhabdomyosarcoma
Phase: Phase II
Type: Treatment
Age: 21 and under
Trial IDs: 04-188, NCI-2011-03349, NCT00592592
Iodine I 131 Monoclonal Antibody 8H9 in Treating Patients with Desmoplastic Small Round Cell Tumors and Other Solid Tumors Involving the Peritoneum
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 1 and over
Trial IDs: 09-090, NCI-2010-01242, NCT01099644
Bevacizumab, Doxorubicin Hydrochloride, and Radiation Therapy in Treating Patients with Soft Tissue Sarcomas That Can Be Removed by Surgery
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 12-396, NCI-2013-01105, ML28479, NCT01746238
Proton Beam Radiation Therapy in Treating Younger Patients with Bone or Non-rhabdomyosarcoma Soft Tissue Sarcomas
Phase: No phase specified
Type: Treatment
Age: 30 and under
Trial IDs: 05-326, NCI-2012-00673, NCT00592293
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 229812, NCI-2013-01198, NCT01896778
Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2705.00, NCI-2013-01779, NCT01957709
Start Over